Leaflet RAPIBLOC 20mg / 2ml concentrate for solution for injection


Indicated for: cardiac arrhythmias

Substance: landiolol (antiarrhythmic)

ATC: C07AB14 (Cardiovascular system | Beta blocking agents | Beta blocking agents, selective)

Landiolol is a medication used to control supraventricular tachycardia and perioperative hypertension. It is an ultra-selective beta-blocker with rapid action that reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors.

The medication is administered intravenously, usually in a hospital setting, under the supervision of a doctor. Due to its rapid onset and short duration of effect, it is ideal for use in acute situations.

Side effects may include low blood pressure, bradycardia, dizziness, or nausea. In rare cases, severe allergic reactions or heart failure may occur.

Patients should inform their doctor about any other medications they are taking and be closely monitored during treatment. Pregnant or breastfeeding women should consult a specialist before use.

General data about RAPIBLOC 20mg / 2ml

  • Substance: landiolol
  • Date of last drug list: 01-05-2026
  • Commercial code: W66025001
  • Concentration: 20mg / 2ml
  • Pharmaceutical form: concentrate for solution for injection
  • Quantity: 5
  • Product type: original
  • Price: 1004.98 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: AMOMED PHARMA GMBH - AUSTRIA
  • Holder: AMOMED PHARMA GMBH - AUSTRIA
  • Number: 14035/2021/01
  • Shelf life: 18 months-after packing for marketing;after the first opening a fiolei-it is used immediately

Pharmaceutical forms available for landiolol

Concentrations available for landiolol

  • 20mg/2ml
  • 300mg
  • 600mg